Connection

Andreas Kronbichler to Rituximab

Back to Details
This is a "connection" page, showing publications Andreas Kronbichler has written about Rituximab.
Andreas Kronbichler
Connection Strength
1.428
Rituximab
  1. Trimethoprim-sulfamethoxazole prophylaxis prevents severe/life-threatening infections following rituximab in antineutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis. 2018 10; 77(10):1440-1447.
    View in: PubMed
    Score: 0.405
  2. Löfgren syndrome as secondary autoimmune disease in a patient with B-cell depletion following rituximab treatment. Clin Exp Rheumatol. 2018 May-Jun; 36(3):515-516.
    View in: PubMed
    Score: 0.397
  3. Rituximab for immunologic renal disease: What the nephrologist needs to know. Autoimmun Rev. 2017 Jun; 16(6):633-643.
    View in: PubMed
    Score: 0.372
  4. COVID-19 and ANCA-associated vasculitis: recommendations for vaccine preparedness and the use of rituximab. Nephrol Dial Transplant. 2021 08 27; 36(9):1758-1760.
    View in: PubMed
    Score: 0.126
  5. Progressive Multifocal Leukoencephalopathy Following Combined Rituximab-Based Immune-Chemotherapy for Post-transplant Lymphoproliferative Disorder in a Renal Transplant Recipient: A Case Report. Transplant Proc. 2018 Apr; 50(3):881-883.
    View in: PubMed
    Score: 0.100
  6. ANCA associated vasculitis: The journey to complement-targeted therapies. Mol Immunol. 2019 08; 112:394-398.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.